Literature DB >> 12697718

Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription.

Miroslava Jezova1, Ines Armando, Claudia Bregonzio, Zu-Xi Yu, Sujuan Qian, Victor J Ferrans, Hans Imboden, Juan M Saavedra.   

Abstract

Angiotensin II (Ang II) AT(1) receptors have been proposed to mediate the Ang II-dependent and the stress-stimulated adrenomedullary catecholamine synthesis and release. However, in this tissue, most of the Ang II receptors are of the AT(2) type. We asked the question whether AT(1) and AT(2) receptors regulate basal catecholamine synthesis. Long-term AT(1) receptor blockade decreased adrenomedullary AT(1) receptor binding, AT(2) receptor binding and AT(2) receptor protein, rat tyrosine hydroxylase (TH) mRNA, norepinephrine (NE) content, Fos-related antigen 2 (Fra-2) protein, phosphorylated cAMP response element binding protein (pCREB), and ERK2. Long-term AT(2) receptor blockade decreased AT(2) receptor binding, TH mRNA, NE content and Fra-2 protein, although not affecting AT(1) receptor binding or receptor protein, pCREB or ERK2. Angiotensin II colocalized with AT(1) and AT(2) receptors in ganglion cell bodies. AT(2) receptors were clearly localized to many, but not all, chromaffin cells. Our data support the hypothesis of an AT(1)/AT(2) receptor cross-talk in the adrenomedullary ganglion cells, and a role for both receptor types on the selective regulation of basal NE, but not epinephrine formation, and in the regulation of basal TH transcription. Whereas AT(1) and AT(2) receptors involve the Fos-related antigen Fra-2, AT(1) receptor transcriptional effects include pCREB and ERK2, indicating common as well as different regulatory mechanisms for each receptor type.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697718     DOI: 10.1210/en.2002-0019

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

2.  Stress triggered changes in gene expression in adrenal medulla: transcriptional responses to acute and chronic stress.

Authors:  Esther L Sabban; Xiaoping Liu; Lidia Serova; Volodia Gueorguiev; Richard Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

Review 3.  Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.

Authors:  J M Saavedra; I Armando
Journal:  Cell Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.046

Review 4.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

5.  Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats.

Authors:  Miroslava Macova; Ines Armando; Jin Zhou; Gustavo Baiardi; Dmitri Tyurmin; Ignacio M Larrayoz-Roldan; Juan M Saavedra
Journal:  Neuroendocrinology       Date:  2008-08-04       Impact factor: 4.914

6.  Regulation of angiotensin II type 2 receptor gene expression in the adrenal medulla by acute and repeated immobilization stress.

Authors:  Regina Nostramo; Andrej Tillinger; Juan M Saavedra; Ashok Kumar; Varunkumar Pandey; Lidia Serova; Richard Kvetnansky; Esther L Sabban
Journal:  J Endocrinol       Date:  2012-08-21       Impact factor: 4.286

7.  Secretin: hypothalamic distribution and hypothesized neuroregulatory role in autism.

Authors:  M G Welch; J D Keune; T B Welch-Horan; N Anwar; M Anwar; R J Ludwig; D A Ruggiero
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

8.  A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.

Authors:  Miroslava Macova; Jaroslav Pavel; Juan M Saavedra
Journal:  Brain Res       Date:  2008-11-12       Impact factor: 3.252

9.  Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.

Authors:  Jaroslav Pavel; Julius Benicky; Yuki Murakami; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.

Authors:  Enrique Sanchez-Lemus; Yuki Murakami; Ignacio M Larrayoz-Roldan; Armen J Moughamian; Jaroslav Pavel; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.